1. Home
  2. NBY vs CXAI Comparison

NBY vs CXAI Comparison

Compare NBY & CXAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NBY
  • CXAI
  • Stock Information
  • Founded
  • NBY 2000
  • CXAI N/A
  • Country
  • NBY United States
  • CXAI United States
  • Employees
  • NBY N/A
  • CXAI N/A
  • Industry
  • NBY
  • CXAI EDP Services
  • Sector
  • NBY
  • CXAI Technology
  • Exchange
  • NBY Nasdaq
  • CXAI Nasdaq
  • Market Cap
  • NBY 15.7M
  • CXAI 17.8M
  • IPO Year
  • NBY 2007
  • CXAI N/A
  • Fundamental
  • Price
  • NBY $1.20
  • CXAI $0.83
  • Analyst Decision
  • NBY Strong Buy
  • CXAI
  • Analyst Count
  • NBY 1
  • CXAI 0
  • Target Price
  • NBY $0.85
  • CXAI N/A
  • AVG Volume (30 Days)
  • NBY 1.2M
  • CXAI 706.8K
  • Earning Date
  • NBY 11-06-2025
  • CXAI 11-11-2025
  • Dividend Yield
  • NBY N/A
  • CXAI N/A
  • EPS Growth
  • NBY N/A
  • CXAI N/A
  • EPS
  • NBY 0.41
  • CXAI N/A
  • Revenue
  • NBY $9,781,000.00
  • CXAI $6,005,000.00
  • Revenue This Year
  • NBY $23.91
  • CXAI N/A
  • Revenue Next Year
  • NBY $32.05
  • CXAI $60.00
  • P/E Ratio
  • NBY $3.52
  • CXAI N/A
  • Revenue Growth
  • NBY 113.47
  • CXAI N/A
  • 52 Week Low
  • NBY $0.46
  • CXAI $0.61
  • 52 Week High
  • NBY $4.44
  • CXAI $2.54
  • Technical
  • Relative Strength Index (RSI)
  • NBY 40.93
  • CXAI 58.85
  • Support Level
  • NBY $1.22
  • CXAI $0.70
  • Resistance Level
  • NBY $1.64
  • CXAI $0.88
  • Average True Range (ATR)
  • NBY 0.24
  • CXAI 0.06
  • MACD
  • NBY -0.16
  • CXAI 0.01
  • Stochastic Oscillator
  • NBY 0.38
  • CXAI 72.71

About NBY NovaBay Pharmaceuticals Inc.

NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare, wound care, and skin care products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material, including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease.

About CXAI CXApp Inc.

CXApp Inc is a provider of AI-powered employee experience solutions, delivering enterprise-grade software that enhances workplace engagement, productivity, and operational efficiency. The company's flagship product, the CXAI Platform, provides a comprehensive suite of tools designed to empower employees and enable organizations to create smarter workplaces. The product's key components include CXAI Apps, CXAI BTS, and CXAI-VU. The company generates the majority of its revenue from Licenses.

Share on Social Networks: